APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dengue Fever Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dengue Fever Testing Market Outlook and Growth Opportunities 2026

12 August 2026191 pages

Choose your research edition.

Industry ResearchDengue Fever Testing Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Dengue Fever Testing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Dengue Fever Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dengue Fever Testing Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Dengue Fever Testing Market Analysis and Forecast 2026-2032175 pages · $4,950 USD

Market perspective

The global Dengue Fever Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dengue Fever Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dengue Fever Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dengue Fever Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dengue Fever Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dengue Fever Testing market include Quest Diagnostics, Certest Biotec, OriGene Technologies, Thermo Fisher, Abnova, Roche Molecular Systems, Abbott Laboratories, InBios International and NovaTec Immundiagnostica, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Dengue Fever Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dengue Fever Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dengue Fever Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Dengue Fever Testing market.

Dengue Fever Testing Segment by Company

Quest Diagnostics

Certest Biotec

OriGene Technologies

Thermo Fisher

Abnova

Roche Molecular Systems

Abbott Laboratories

InBios International

NovaTec Immundiagnostica

Sub.PerkinElmer

Dengue Fever Testing Segment by Type

ELISA-Based Tests

RT-PCR Based Tests

Dengue IgG/IgM Rapid Test

Dengue Fever Testing Segment by Application

Hospitals

Public Health Laboratory

Diagnostic Centers

Others

Dengue Fever Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dengue Fever Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Dengue Fever Testing key companies, revenue, market share, and recent developments.

3. To split the Dengue Fever Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Dengue Fever Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dengue Fever Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Dengue Fever Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dengue Fever Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dengue Fever Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dengue Fever Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dengue Fever Testing industry.

Chapter 3: Detailed analysis of Dengue Fever Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Dengue Fever Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Dengue Fever Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dengue Fever Testing Industry Trends Table 2. Dengue Fever Testing Industry Drivers Table 3. Dengue Fever Testing Industry Opportunities and Challenges Table 4. Dengue Fever Testing Industry Restraints Table 5. Global Dengue Fever Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dengue Fever Testing Revenue Share by Company (2021-2026) Table 7. Global Dengue Fever Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Dengue Fever Testing Key Company Manufacturing Base & Headquarters Table 9. Global Dengue Fever Testing Company, Product Type & Application Table 10. Global Dengue Fever Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Dengue Fever Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of ELISA-Based Tests Table 15. Significant Companies of RT-PCR Based Tests Table 16. Significant Companies of Dengue IgG/IgM Rapid Test Table 17. Global Dengue Fever Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Dengue Fever Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Dengue Fever Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Dengue Fever Testing Sales Value Share by Type (2021-2026) Table 21. Global Dengue Fever Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Public Health Laboratory Table 24. Significant Companies of Diagnostic Centers Table 25. Significant Companies of Others Table 26. Global Dengue Fever Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Dengue Fever Testing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Dengue Fever Testing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Dengue Fever Testing Sales Value Share by Application (2021-2026) Table 30. Global Dengue Fever Testing Sales Value Share by Application (2027-2032) Table 31. Global Dengue Fever Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Dengue Fever Testing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Dengue Fever Testing Sales Value Share by Region (2021-2026) Table 34. Global Dengue Fever Testing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Dengue Fever Testing Sales Value Share by Region (2027-2032) Table 36. Global Dengue Fever Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Dengue Fever Testing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Dengue Fever Testing Sales Value Market Share by Country (2021-2026) Table 39. Global Dengue Fever Testing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Dengue Fever Testing Sales Value Market Share by Country (2027-2032) Table 41. Quest Diagnostics Company Information Table 42. Quest Diagnostics Business Overview Table 43. Quest Diagnostics Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Quest Diagnostics Dengue Fever Testing Product Portfolio Table 45. Quest Diagnostics Recent Development Table 46. Certest Biotec Company Information Table 47. Certest Biotec Business Overview Table 48. Certest Biotec Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Certest Biotec Dengue Fever Testing Product Portfolio Table 50. Certest Biotec Recent Development Table 51. OriGene Technologies Company Information Table 52. OriGene Technologies Business Overview Table 53. OriGene Technologies Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. OriGene Technologies Dengue Fever Testing Product Portfolio Table 55. OriGene Technologies Recent Development Table 56. Thermo Fisher Company Information Table 57. Thermo Fisher Business Overview Table 58. Thermo Fisher Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Thermo Fisher Dengue Fever Testing Product Portfolio Table 60. Thermo Fisher Recent Development Table 61. Abnova Company Information Table 62. Abnova Business Overview Table 63. Abnova Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Abnova Dengue Fever Testing Product Portfolio Table 65. Abnova Recent Development Table 66. Roche Molecular Systems Company Information Table 67. Roche Molecular Systems Business Overview Table 68. Roche Molecular Systems Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Roche Molecular Systems Dengue Fever Testing Product Portfolio Table 70. Roche Molecular Systems Recent Development Table 71. Abbott Laboratories Company Information Table 72. Abbott Laboratories Business Overview Table 73. Abbott Laboratories Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Abbott Laboratories Dengue Fever Testing Product Portfolio Table 75. Abbott Laboratories Recent Development Table 76. InBios International Company Information Table 77. InBios International Business Overview Table 78. InBios International Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. InBios International Dengue Fever Testing Product Portfolio Table 80. InBios International Recent Development Table 81. NovaTec Immundiagnostica Company Information Table 82. NovaTec Immundiagnostica Business Overview Table 83. NovaTec Immundiagnostica Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. NovaTec Immundiagnostica Dengue Fever Testing Product Portfolio Table 85. NovaTec Immundiagnostica Recent Development Table 86. Sub.PerkinElmer Company Information Table 87. Sub.PerkinElmer Business Overview Table 88. Sub.PerkinElmer Dengue Fever Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sub.PerkinElmer Dengue Fever Testing Product Portfolio Table 90. Sub.PerkinElmer Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Dengue Fever Testing Product Image Figure 2. Global Dengue Fever Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dengue Fever Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Dengue Fever Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. ELISA-Based Tests Image Figure 8. RT-PCR Based Tests Image Figure 9. Dengue IgG/IgM Rapid Test Image Figure 10. Global Dengue Fever Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Dengue Fever Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Dengue Fever Testing Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Public Health Laboratory Image Figure 15. Diagnostic Centers Image Figure 16. Others Image Figure 17. Global Dengue Fever Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Dengue Fever Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Dengue Fever Testing Sales Value Share by Application (2021-2032) Figure 20. Global Dengue Fever Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Dengue Fever Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Dengue Fever Testing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Dengue Fever Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Dengue Fever Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Dengue Fever Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Dengue Fever Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Dengue Fever Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Dengue Fever Testing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Dengue Fever Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Dengue Fever Testing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Dengue Fever Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Dengue Fever Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA-Based Tests
  • RT-PCR Based Tests
  • Dengue IgG/IgM Rapid Test
Applications
  • Hospitals
  • Public Health Laboratory
  • Diagnostic Centers
  • Others
Companies covered
  • Quest Diagnostics
  • Certest Biotec
  • OriGene Technologies
  • Thermo Fisher
  • Abnova
  • Roche Molecular Systems
  • Abbott Laboratories
  • InBios International
  • NovaTec Immundiagnostica
  • Sub.PerkinElmer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dengue Fever Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dengue Fever Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Dengue Fever Testing Market Dynamics
  1. 2.1 Dengue Fever Testing Industry Trends
  2. 2.2 Dengue Fever Testing Industry Drivers
  3. 2.3 Dengue Fever Testing Industry Opportunities and Challenges
  4. 2.4 Dengue Fever Testing Industry Restraints
3 Dengue Fever Testing Market by Company
  1. 3.1 Global Dengue Fever Testing Company Revenue Ranking in 2025
  2. 3.2 Global Dengue Fever Testing Revenue by Company (2021-2026)
  3. 3.3 Global Dengue Fever Testing Company Ranking (2024-2026)
  4. 3.4 Global Dengue Fever Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Dengue Fever Testing Company Product Type and Application
  6. 3.6 Global Dengue Fever Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Dengue Fever Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Dengue Fever Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Dengue Fever Testing Market by Type
  1. 4.1 Dengue Fever Testing Type Introduction
  2. 4.1.1 ELISA-Based Tests
  3. 4.1.2 RT-PCR Based Tests
  4. 4.1.3 Dengue IgG/IgM Rapid Test
  5. 4.2 Global Dengue Fever Testing Sales Value by Type
  6. 4.2.1 Global Dengue Fever Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Dengue Fever Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Dengue Fever Testing Sales Value Share by Type (2021-2032)
5 Dengue Fever Testing Market by Application
  1. 5.1 Dengue Fever Testing Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Public Health Laboratory
  4. 5.1.3 Diagnostic Centers
  5. 5.1.4 Others
  6. 5.2 Global Dengue Fever Testing Sales Value by Application
  7. 5.2.1 Global Dengue Fever Testing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Dengue Fever Testing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Dengue Fever Testing Sales Value Share by Application (2021-2032)
6 Dengue Fever Testing Regional Value Analysis
  1. 6.1 Global Dengue Fever Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dengue Fever Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Dengue Fever Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Dengue Fever Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dengue Fever Testing Sales Value (2021-2032)
  7. 6.3.2 North America Dengue Fever Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Dengue Fever Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Dengue Fever Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Dengue Fever Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Dengue Fever Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Dengue Fever Testing Sales Value (2021-2032)
  16. 6.6.2 South America Dengue Fever Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Dengue Fever Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Dengue Fever Testing Sales Value Share by Country, 2025 VS 2032
7 Dengue Fever Testing Country-level Value Analysis
  1. 7.1 Global Dengue Fever Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dengue Fever Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Dengue Fever Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Dengue Fever Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Dengue Fever Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Dengue Fever Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Dengue Fever Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quest Diagnostics
  2. 8.1.1 Quest Diagnostics Company Information
  3. 8.1.2 Quest Diagnostics Business Overview
  4. 8.1.3 Quest Diagnostics Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Quest Diagnostics Dengue Fever Testing Product Portfolio
  6. 8.1.5 Quest Diagnostics Recent Developments
  7. 8.2 Certest Biotec
  8. 8.2.1 Certest Biotec Company Information
  9. 8.2.2 Certest Biotec Business Overview
  10. 8.2.3 Certest Biotec Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Certest Biotec Dengue Fever Testing Product Portfolio
  12. 8.2.5 Certest Biotec Recent Developments
  13. 8.3 OriGene Technologies
  14. 8.3.1 OriGene Technologies Company Information
  15. 8.3.2 OriGene Technologies Business Overview
  16. 8.3.3 OriGene Technologies Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 OriGene Technologies Dengue Fever Testing Product Portfolio
  18. 8.3.5 OriGene Technologies Recent Developments
  19. 8.4 Thermo Fisher
  20. 8.4.1 Thermo Fisher Company Information
  21. 8.4.2 Thermo Fisher Business Overview
  22. 8.4.3 Thermo Fisher Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Dengue Fever Testing Product Portfolio
  24. 8.4.5 Thermo Fisher Recent Developments
  25. 8.5 Abnova
  26. 8.5.1 Abnova Company Information
  27. 8.5.2 Abnova Business Overview
  28. 8.5.3 Abnova Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Abnova Dengue Fever Testing Product Portfolio
  30. 8.5.5 Abnova Recent Developments
  31. 8.6 Roche Molecular Systems
  32. 8.6.1 Roche Molecular Systems Company Information
  33. 8.6.2 Roche Molecular Systems Business Overview
  34. 8.6.3 Roche Molecular Systems Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roche Molecular Systems Dengue Fever Testing Product Portfolio
  36. 8.6.5 Roche Molecular Systems Recent Developments
  37. 8.7 Abbott Laboratories
  38. 8.7.1 Abbott Laboratories Company Information
  39. 8.7.2 Abbott Laboratories Business Overview
  40. 8.7.3 Abbott Laboratories Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Abbott Laboratories Dengue Fever Testing Product Portfolio
  42. 8.7.5 Abbott Laboratories Recent Developments
  43. 8.8 InBios International
  44. 8.8.1 InBios International Company Information
  45. 8.8.2 InBios International Business Overview
  46. 8.8.3 InBios International Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 InBios International Dengue Fever Testing Product Portfolio
  48. 8.8.5 InBios International Recent Developments
  49. 8.9 NovaTec Immundiagnostica
  50. 8.9.1 NovaTec Immundiagnostica Company Information
  51. 8.9.2 NovaTec Immundiagnostica Business Overview
  52. 8.9.3 NovaTec Immundiagnostica Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 NovaTec Immundiagnostica Dengue Fever Testing Product Portfolio
  54. 8.9.5 NovaTec Immundiagnostica Recent Developments
  55. 8.10 Sub.PerkinElmer
  56. 8.10.1 Sub.PerkinElmer Company Information
  57. 8.10.2 Sub.PerkinElmer Business Overview
  58. 8.10.3 Sub.PerkinElmer Dengue Fever Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sub.PerkinElmer Dengue Fever Testing Product Portfolio
  60. 8.10.5 Sub.PerkinElmer Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst